Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HALLIBURTON CO Director's Dealing 2003

Aug 4, 2003

30269_dirs_2003-08-04_111b7d94-d831-414a-b4b4-3a5696ac94f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HALLIBURTON CO (HAL)
CIK: 0000045012
Period of Report: 2003-07-31

Reporting Person: DERR KENNETH T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-08-01 Common Stock A 1800 Acquired 5600 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2003-07-31 Stock Equivalent Units $ A 531.5 Acquired Common Stock (531.5) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option to Buy Common Stock $45.35 2011-05-05 Common Stock (5000) 5000 Direct
Option to Buy Common Stock $16.75 2012-05-15 Common Stock (2000) 2000 Direct

Footnotes

F1: 400 shares awarded pursuant to Halliburton Company's Restricted Stock Plan for Non-Employee Directors. 1400 shares awarded pursuant to Halliburton Company's 1993 Stock and Incentive Plan.

F2: On August 1, 2003, the closing price of Halliburton Company Common Stock on the New York Stock Exchange was $22.24 per share.

F3: The security converts to common stock on a one-for-one basis.

F4: Stock equivalents acquired under Halliburton Company's Directors' Deferred Compensation Plan reported on a pro rata basis to reflect Issuer's Plan quarter. Said Plan is an ongoing securities acquisition plan.

F5: The stock equivalent units were accrued under the Company's Directors' Deferred Compensation Plan and are settled in the Company's common stock upon cessation as a director.

F6: On July 30, 2003, the closing price of Halliburton Company Common Stock on the New York Stock Exchange was $21.11 per share.

F7: Options are exercisable six months after the date of grant.